Mydran 0.02%+0.31%+1%

Mydran 0.02%+0.31%+1% | INDICATIONS AND USES

This is indicated for cataract surgery to obtain mydriasis (dilation of the pupil) and intraocular anesthesia during the surgical procedure.

Mydran 0.02%+0.31%+1% | DOSAGE & ADMINISTRATION

Used only in the elderly and adults undergoing cataract surgery. The injection has to be administered by an ophthalmic surgeon, under local anesthesia, at the beginning of cataract surgery. The recommended dose is 0.2 ml of solution, in only one injection. The following procedure should be followed:

Five minutes before performing the preoperative antiseptic procedure and the first incision, one to two drops of anesthetic eye drops should be instilled in the eye.
At the beginning of surgery, 0.2 ml of the drop is slowly injected in only one injection via intracameral route, through the side port or principal port.

Mydran 0.02%+0.31%+1% | SIDE EFFECTS

Most serious well-known complications occurring during or after cataract surgery:Uncommon: may affect up to 1 in 100 people

Injury to the lens (posterior capsule rupture)
Swelling of the retina (cystoid macular edema)

Please seek urgent medical advice in this case.Other side effects:Uncommon: may affect up to 1 in 100 people

Nervous system disorder: Headache
Eye Disorder: Swelling of the cornea (keratitis), increased pressure in the eye, redness of the eye (ocular hyperaemia)
Vascular disorder: High blood pressure (hypertension)

Mydran 0.02%+0.31%+1% | USE DURING PREGNANCY AND LACTATION

This medicine should not be used during pregnancy and lactation.

Mydran 0.02%+0.31%+1% | PRECAUTIONS & WARNINGS

Do not use if the blister is damaged or broken. Open under aseptic conditions only. The product should be used immediately after opening of the ampoule and not be reused for the other eye or any other patient. This is not recommended:

In combined cataract surgery with a certain type of eye surgery (vitrectomy)
If the ocular anterior chamber is shallow
If the patient has a history of acute narrow angle glaucoma

The doctor should consider the patient’s medical condition if he is suffering from hypertension, atherosclerosis or any kind of heart disease, hyperthyroidism, prostate gland disorders, epilepsy, any liver disease or kidney problem, breathing problem or myasthenia gravis.

Mydran 0.02%+0.31%+1% | THERAPEUTIC CLASS

Other ophthalmic preparations

Mydran 0.02%+0.31%+1% | STORAGE CONDITIONS

Do not store above 30⁰C. Does not require refrigeration. Keep away from light and out of the reach of children. For single eye use only. This medicine should be used immediately after first opening of the ampoule. After use, discard the remaining solution appropriately. Do not keep it for subsequent use.